DE69614681T2 - Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten - Google Patents

Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten

Info

Publication number
DE69614681T2
DE69614681T2 DE69614681T DE69614681T DE69614681T2 DE 69614681 T2 DE69614681 T2 DE 69614681T2 DE 69614681 T DE69614681 T DE 69614681T DE 69614681 T DE69614681 T DE 69614681T DE 69614681 T2 DE69614681 T2 DE 69614681T2
Authority
DE
Germany
Prior art keywords
carnosine
compositions
amino acids
derivatives
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69614681T
Other languages
German (de)
English (en)
Other versions
DE69614681D1 (de
Inventor
Roberto Bianchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
FARMILA FARMA MILANO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FARMILA FARMA MILANO filed Critical FARMILA FARMA MILANO
Publication of DE69614681D1 publication Critical patent/DE69614681D1/de
Application granted granted Critical
Publication of DE69614681T2 publication Critical patent/DE69614681T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DE69614681T 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten Expired - Lifetime DE69614681T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
PCT/EP1996/002079 WO1996036348A1 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids

Publications (2)

Publication Number Publication Date
DE69614681D1 DE69614681D1 (de) 2001-09-27
DE69614681T2 true DE69614681T2 (de) 2002-07-04

Family

ID=11371632

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614681T Expired - Lifetime DE69614681T2 (de) 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten

Country Status (11)

Country Link
US (1) US5866537A (https=)
EP (1) EP0825871B1 (https=)
JP (1) JP4850986B2 (https=)
AT (1) ATE204479T1 (https=)
AU (1) AU697990B2 (https=)
CA (1) CA2221455C (https=)
DE (1) DE69614681T2 (https=)
ES (1) ES2159737T3 (https=)
IT (1) IT1275434B (https=)
PT (1) PT825871E (https=)
WO (1) WO1996036348A1 (https=)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE332127T1 (de) * 1994-11-08 2006-07-15 Avicena Group Inc Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
US6168802B1 (en) 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6274161B1 (en) 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
DE19806890A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
WO1999051097A1 (en) * 1998-04-02 1999-10-14 Avicena Group, Inc. Compositions containing a combination of a creatine compound and a second agent
US20060128671A1 (en) * 1998-04-02 2006-06-15 The General Hospital Corporation Compositions containing a combination of a creatine compound and a second agent
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
CA2338638C (en) 1998-07-30 2009-03-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
CA2339473A1 (en) * 1998-08-04 2000-02-17 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
NO993678L (no) * 1999-07-28 2001-01-29 Norsk Hydro As Fôr for salmonider
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
CA2420562C (en) * 2000-09-14 2011-03-29 Board Of Regents Of The University Of Nebraska Creatine ester pronutrient compounds and formulations
ATE328596T1 (de) * 2001-03-16 2006-06-15 Suntory Ltd Autonomsystem kontrollagentien und gesundheitsgetränke und -nahrungsmittel
EP1567180A4 (en) * 2002-06-04 2010-03-10 Avicena Group Inc METHOD FOR THE TREATMENT OF COGNITIVE DYSFUNCTION BY MODULATING THE CHANGE OF ENERGY REPLACEMENT IN THE BRAIN
TR200301291A2 (tr) * 2002-08-20 2004-02-23 Dart Industries Inc. Şekil verilmiş gıda maddelerinin oluşturulması için ayarlanabilir kalıp
EP1551399A4 (en) * 2002-09-30 2011-01-05 Mark A Babizhayev METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT
JPWO2004064866A1 (ja) * 2003-01-20 2006-05-18 イノヴェイティブ ヴィジョン プロダクツ インコーポレーテッド カルノシナーゼ阻害剤とl−カルノシン類との併用および組成物
RU2255758C2 (ru) * 2003-09-18 2005-07-10 Закрытое акционерное общество "Научно-производственное объединение "ТЕХКОН" Биологически активный карнозин-анзеринсодержащий комплекс и способ его получения
SI1591105T1 (sl) 2004-03-17 2020-09-30 Stada Arzneimittel Ag Uporaba antioksidantov za pripravo farmacevtskega ali kozmetičnega sestavka za zaščito kože pred poškodbo z infrardečim sevanjem
EP1761272B1 (en) 2004-06-08 2013-04-24 Flamma S.P.A. Compositions containing d-carnosine
JP2006052186A (ja) * 2004-08-16 2006-02-23 Toagosei Co Ltd 新規ジヒドロフェルラ酸縮合物
WO2006026304A1 (en) * 2004-08-25 2006-03-09 Ivax Corporation Cardioprotective formulations and uses thereof
CA2621365C (en) 2005-05-23 2012-09-04 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
AU2007249847A1 (en) * 2006-05-11 2007-11-22 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
RU2318512C1 (ru) * 2006-09-01 2008-03-10 ГУ Научно-исследовательский институт психического здоровья Томского научного центра Сибирского отделения Российской академии медицинских наук ГУ НИИ психического здоровья ТНЦ СО РАМН Способ реабилитации больных алкоголизмом на этапе формирования ремиссии
US9421262B2 (en) * 2009-10-28 2016-08-23 Biomed Research & Technologies, Inc. Compositions and methods for treating dermatological conditions
JPWO2011078204A1 (ja) * 2009-12-24 2013-05-09 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
EP2654777A4 (en) * 2010-12-21 2014-07-09 Nestec Sa METHOD AND COMPOSITIONS FOR ADMINISTERING THE BLOOD SUGAR IN ANIMALS
US9233099B2 (en) 2012-01-11 2016-01-12 University Of Cincinnati Methods of treating cognitive dysfunction by modulating brain energy metabolism
JP2014114244A (ja) * 2012-12-11 2014-06-26 Ito En Ltd 抗疲労剤組成物
JP6401028B2 (ja) * 2014-11-27 2018-10-03 Shiodaライフサイエンス株式会社 鯨筋肉抽出物からなる中長期記憶障害予防改善剤
JP2016130229A (ja) * 2015-01-15 2016-07-21 有限会社アント アミノ酸溶解物の製造方法および該製造方法により製造したアミノ酸溶解物
FR3056381B1 (fr) * 2016-09-26 2019-11-15 Futur Optimal Composition comprenant de la carnosine
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
US20220218640A1 (en) 2021-01-14 2022-07-14 Rob Dickerman Amino acid delivery system
JP7848039B2 (ja) * 2022-04-13 2026-04-20 サントリーホールディングス株式会社 組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica

Also Published As

Publication number Publication date
ITMI951021A1 (it) 1996-11-19
AU697990B2 (en) 1998-10-22
US5866537A (en) 1999-02-02
ATE204479T1 (de) 2001-09-15
IT1275434B (it) 1997-08-07
JPH11505540A (ja) 1999-05-21
CA2221455C (en) 2008-07-08
DE69614681D1 (de) 2001-09-27
PT825871E (pt) 2001-12-28
CA2221455A1 (en) 1996-11-21
AU5897496A (en) 1996-11-29
ITMI951021A0 (it) 1995-05-19
ES2159737T3 (es) 2001-10-16
JP4850986B2 (ja) 2012-01-11
WO1996036348A1 (en) 1996-11-21
EP0825871A1 (en) 1998-03-04
EP0825871B1 (en) 2001-08-22

Similar Documents

Publication Publication Date Title
DE69614681T2 (de) Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
DE69331528T2 (de) Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
DE3587766T2 (de) Verbesserungen am geschmack von zinkzusätzen für orale verwendung.
DE69710557T2 (de) Zinc, Kupferverbindung und Aminosäure enthaltende Zusammensetzung zur oralen Verabreichung
DE69330885T2 (de) Medizinisches nahrungsmittel für zusatznahrung von kinder/erwachsenen mit stoffwechselerkrankungen
US5716926A (en) Composition of pyruvate and protein and method for increasing protein concentration in a mammal
DE3587216T2 (de) Koernige diaetetische produkte auf der basis von aminosaeuren und verfahren zu ihrer herstellung.
EP2114174B1 (de) Verwendung von guanidinoessigsäure(-salzen) in kombination mit betain und/oder cholin zur herstellung eines gesundheitsfördernden mittels
DE102004017076A1 (de) Verwendung von gamma-Aminobuttersäure zur Maskierung oder Verminderung eines unangenehmen Geschmackseindrucks sowie Zubereitungen enthaltend gamma-Aminobuttersäure
DE2741003A1 (de) Aus collagenhaltigem material oder gelatine erhaltene peptidmischungen, verfahren zu deren herstellung und deren verwendungen
DE69806590T2 (de) Feste zusammensetzungen für orale verabreichung die l-carnitine oder alkanoyl-l-carnitin-magnesium-fumarat enthalten
EP1853248B1 (de) Verwendung der SALZE, ANLAGERUNGS- UND KOMPLEXVERBINDUNGEN DER GUANIDINOESSIGSÄURE
DE2921852A1 (de) Lipide senkendes mittel
DE10221403A1 (de) Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
EP2234506A1 (de) Zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung
EP1909601B1 (de) Flüssig-formulierung auf basis einer guanidinoessigsäure-komponente
EP1326502A2 (de) Verfahren zur herstellung einer granulierbaren mischung und carnitin-magnesium-hydroxycitrat
DE60032509T2 (de) Chrom-histidin-komplexe als nahrungsmittelzusätze
EP1345502A1 (de) Kreatin/citronensäure-verbindung, verfahren zu ihrer herstellung und verwendung
EP1575593A2 (de) VERWENDUNG VON TETRAHYDROBIOPTERINDERIVATEN ZUR BEHANDLUNG UND ERN HRUNG VON PATIENTEN MIT AMINOS URESTOFFWECHSELST&Ouml ;RUNGEN
EP3357352A1 (de) Zusammensetzung mit aminosäuren
DE69522723T2 (de) Antiallergisches Mittel und Nährstoffzusammensetzung, die Glutamin enthalten
DE2712777A1 (de) Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
DE69802512T2 (de) Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten
DE68903448T2 (de) Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIGMA-TAU HEALTHSCIENCE S.P.A., POMEZIA, IT

8327 Change in the person/name/address of the patent owner

Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P, IT